PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.50 (1.12%)
Spread: 2.00 (4.545%)
Open: 44.50
High: 45.00
Low: 44.50
Prev. Close: 44.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition revenue climbs despite swing to annual loss

Wed, 03rd May 2023 17:21

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it had a "transformative" 2022, as revenue climbed 25% against the previous year.

The Cambridge, England-based digital health products technology developer said revenue in 2022 rose to GBP12.6 million, up 25% from GBP10.1 million a year earlier. Services revenue grew by 16% in 2022 to GBP6.5 million, whilst Software revenue climbed 39% to GBP5.0 million.

However, the company swung to a pretax loss of GBP600,000 from a pretax profit of GBP300,000 year-on-year. It also swung to a loss per share of 1.3 pence, from an earnings per share of 1.4 pence.

The financial results for the year were tempered by a slightly slower-than-expected final quarter, as the company experienced delays and scope reduction associated with large orders, Cambridge Cognition explained. It added that market forecasts suggest that this is not representative of a long-term trend.

The company ended 2022 with a contracted order book of GBP17.6 million, which increased further to GBP19.1 million in January, following the acquisition of Winterlight Labs.

Cambridge Cognition bought Winterlight Labs for GBP7.0 million back in January.

Looking ahead, Cambridge Cognition said that its strong contracted order book provides "excellent" revenue visibility through 2023.

"2022 was a transformational year for Cambridge Cognition, marked by significant multi-year orders, sustained revenue growth, and the expansion of our core product set," said Chief Executive Officer Matthew Stork.

"Looking ahead, we remain committed to our objectives of driving revenue and profit growth by increasing our market share through offering the most innovative technology, supported by outstanding scientific evidence and a very experienced team, in the high-value market for CNS drug development."

Shares in Cambridge Cognition closed down 4.6% to 93.00 pence each.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Sep 2019 16:33

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

Read more
23 Sep 2019 17:13

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

Read more
19 Sep 2019 11:52

Cambridge Cognition Interim Revenue Falls As Clinical Trial Sales Lag

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC on Thursday reported a fall in interim revenue in line with previous guidance that sales were lower than the six

Read more
12 Sep 2019 16:21

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 13 September  JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment

Read more
27 Aug 2019 10:28

WINNERS & LOSERS SUMMARY: Carpetright Up After Shareholder Helps Out

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - LOSERS----------Ferguson,

Read more
27 Aug 2019 09:35

Cambridge Cognition Shares Plunge 40% On Increased Loss Guidance

(Alliance News) - Shares in Cambridge Cognition Holdings PLC collapsed Tuesday after the company said it expects to report its loss widened in the first half due to "difficult" trading a

Read more
27 Aug 2019 09:17

Cambridge Cognition shares tumble after profit warning

(Sharecast News) - Digital solutions developer Cambridge Cognition warned on Tuesday that interim losses looked set to widen after revenues dwindled and costs grew in the six months ended 30 June.

Read more
19 Jul 2019 10:37

Cambridge Cognition Inks NeuroVocalix Deal With Pharma Firm

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC said it has secured a second commercial partnership with an undisclosed pharmaceutical company for its in the at

Read more
1 Jul 2019 15:48

Cambridge Cognition Names Vertual Boss Debra Leeves As Non-Executive

(Alliance News) - Cambridge Cognition Holdings PLC on Monday said it appointed Debra Leeves as a non-executive director with immediate effect.The neuroscience technology company said Leeves

Read more
25 Apr 2019 14:13

Cambridge Cognition To Shuffle Leadership Team At AGM

LONDON (Alliance News) - Neuroscience firm Cambridge Cognition Holdings PLC on Thursday announced a change of leadership at its upcoming annual general meeting.Cambridge Cognition's be

Read more
19 Mar 2019 11:20

Cambridge Cognition wins biggest digital health contract to date

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced a "significant" new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.

Read more
14 Mar 2019 14:03

Lombard Odier Asset Management Holds 5.8% Cambridge Cognition Stake (ALLISS)

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that Lombard Odier Asset Management Europe Ltd holds a 5.75% stake in the cognitive assessment software firm after a on the

Read more
7 Mar 2019 12:32

Cambridge Cognition slips as low order intake sends loss deeper

(Sharecast News) - Cambridge Cognition's shares slipped on Thursday after it reported that low order intake from 2017 had caused its annual losses to widen and revenues to fall.

Read more
31 Jan 2019 13:28

Cambridge Cognition soars on Indian software partnership

(Sharecast News) - Cambridge Cognition leapt on Thursday after entering a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using its cloud-based CANTAB Connect platform.

Read more
19 Dec 2018 08:52

Cambridge Cognition shares tumble as revenues fall short of expectations

(Sharecast News) - Neuroscience technology developer Cambridge Cognition has seen revenues fall short of expectations and losses widen as a result of a switch in accounting practices.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.